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S_nary A retrospective analysis of ovaran cancer patients registered with the West Midlands Cancer
Registry from I January 1985 to 31 December 1987 was undertaken to examine the variables associated with
survival patters, with particular reference to the specialty of the surgeon. A total of 1,654 patients were
registered, of whom 1,184 had histologically confirmed ovarian cancer, with the operator identified. This
consisted of 870 patients operated on by gynaecologists and 314 operated on by gencral surgeons. A
significantly older population and a greater number of patients with stage tU/IV dises were operated on by
genral surgeons. The median sunrival of patients under the general surgeons' care was 9.87 months,
significantly lower (P<0.0001) than the survival of the gynaecolgst' patients (median survival = 29.1
months). Univariate and multivariate analysis correlated poor prognosis with advancd stage disease, older
age, the presence of bulky residual tumour and a general surgeon as the operator. Stepwise Cox's proportional
hazard analysis confirmed the general surgeon as an indpendent adverse prognostic factor with a relative
hazard ratio of 1.34 (95% confidence interval = 1.05-1.71). Accepting the imitations of retrospective rviews,
these findings suggt that every attempt be made to ensure that a gynaecokogit is involved in the treatment of
patients with ovarian pathology.
Over 5,000 women present with ovarian cancer each year in
England and Wales, with an associated mortality rate of
approximately 4,000, making this the most common cause of
death from gynaecological malignancies (OPCS, 1993).
Recognised prognostic indicators include age, performance
status, disease stage, presenting and residual tumour load,
tumour histology and differentiation, tumour ploidy patterns,
the presence of ascitic fluid and response to chemotherapy
(Friedlander & Dembo, 1991; Lund & Williamson, 1991).
Surgical staging with a hysterectomy, bilateral salpingo-
oophorectomy and omentectomy, followed by adjuvant
chemotherapy, is the basis of treatment in many cases. If not
all the tumour can be excised, debulkling of disease is recom-
mended, as such an approach is presently considered to
improve outcome (DOH, 1991). Owing to the non-specific
symptoms in ovarian cancer, many patients are primarily
referred to other specialists (Timm, 1973), and inevitably not
all are operated on by a gynaecologist. The possibility that
the surgeon affects survival patterns has received little atten-
tion. This study was undertaken to investigate whether the
specalisation of the operating surgeon influences patient sur-
vival.
Patiens and metho
The West Midlands Regional Cancer Registry maintains
computerised and paper records of all cancers diagnosed in
residents of the West Midlands Health Authority Region.
Ovarian cancer cases registered between 1 January 1985 and
31 December 1987 were identified from the computer and the
paper records for the patients examined. These records con-
tain the information transcribed directly from the patients'
notes by the registry staff, pertainmg to surgery, procedure,
tumour type and grade, along with correspondence available
and follow-up information. The information extracted for
this study included histology, tumour differentiation, disease,
stage, age at operation, surgery performed, operating
surgeon, vital status and survival time. All information was
collected by one author (S.K.). Where insufficient data were
available to permit accurate estimation of the stage and other
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variables, or no comment was presented regarding the
residual disease staus, this information was considered un-
known. Notes from 67 patients were ass by a snior
collague to ascertain the concorda with S.K. and this
achieved 100% in practically all aspects oftargeted data. The
largs difference was 1% due to reading error. Therefore any
data compied on the computer which was questionable (i.e.
presence of residual disease and stage I) resulted in a review
ofall cases. If no death date was recorded, follow-up inform-
ation was sought from the patient's general practitioner and
NHS Central Registry. The disease was staged according to
FIGO (1977) criteria.
Statistical analysis was undertaken using the BMDP statis-
tical package (BDMP, 1981). Only patients for whom the
operating surgeon was known were included. Patients were
grouped for analysis according to the specialty ofthe surgeon
(gynaecologist or general surgeon). Univariate methods
(Mann-Whitney U-test and standard error of differences in
proportions) (Armitage & Berry, 1987) were used to examine
the characterstics of both groups. Survival was analysed
using Kaplan-Meier (Kaplan & Meier, 1958) curves and the
log-rankl test. Where the distribution of prognostic factors in
the groups differed significntly, stratified survival analysis
was employed. Finally, a multivariate analysis (stepwise
Cox's proportional hazards model; Cox, 1972) was under-
taken on a subset of patients for whom complete data were
available.
Res
A total of 1,654 patients were registered during the 3 year
study period. From this population 1,184 patients underwent
surgery with the operating surgeon identified. The other 470
patients were excluded for the following reasons: post-
mortem diagnosis (75), diagnosis not confirmed, i.e. cinical
diagnosis (no surgery) (185), inadequate information (74),
surgeon not identified (85), not ovarian malignancy (18) and
duplication of records (33).
Patient characteristics are shown in Table I. The significant
differences noted between the two groups were: a higher
median age and more advanced disease stage in patients
treated by the general surgeons (P<0.0001), and a higher
number of endometrioid tumours in patients dealt with by
gynaecologists (P<0.0001). Also, more of the general
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Table I Patients characteristics
General Significance
Gynaecologist surgeon Total of difference
Number (%) 870 (73.5) 314 (26.5) 1184 (100)
Age (years)
Median 60 66 62
Range 12-96 1-96 1-96
Stage
1 305 (35.1) 45 (14.3) 350 (29.6)
11 76 (8.7) 11 (3.5) 87 (7.3) **
III 358 (41.1) 170 (54.1) 528 (44.6) ***
IV 46 (5.3) 32 (10.2) 78 (6.6) **
NK 85 (9.8) 56 (17.8) 141 (11.9)
Histology
Adenocarcinoma (unspecified) 321 (36.9) 156 (49.7) 477 (40.3)
Serous 180 (20.7) 60 (19.1) 240 (20.3)
Mucinous 143 (16.4) 42 (13.4) 185 (15.6)
Endometrioid 81 (9.3) 11 (3.5) 92 (7.8)
Clear cell 25 (2.9) 10 (3.2) 35 (3.0)
Granulosa cell 23 (2.6) 6 (1.9) 29 (2.4)
Germ cell 18 (2.1) 3 (1.0) 21 (1.8)
Borderline 41 (4.7) 11 (3.5) 52 (4.4)
Others 13 (1.5) 2 (0.6) 15 (1.3)
NK' 25 (2.9) 13 (4.1) 38 (3.2)
Grade
I 151 (17.4) 35 (11.1) 186 (15.7) **
II 141 (16.2) 46 (14.6) 187 (15.8)
III 192 (22.1) 97 (30.9) 289 (24.4) **
NK 386 (44.4) 136 (43.3) 522 (44.1)
Residual disease
None 278 (32.0) 37 (11.8) 315 (26.6) *
Peritoneal seedlings 44 (5.1) 17 (5.4) 61 (5.2)
<2cm maximum diameter 33 (3.8) 8 (2.5) 41 (3.5)
>2cm maximum diameter 253 (29.1) 141 (44.9) 394 (33.2) *
NK 262 (30.1) 111 (35.4) 373 (31.6)
*P<0.05. **P<0.01, ***P<0.001, ****P<0.0001. aOriginal histology not seen, but reports
confirmed malignancy.
surgeons patients had tumours classified as adenocarcinomas
or of poorer differentiation.
Crude survival rates were significantly lower in those
operated on by general surgeons (P<0.001), with a 5 year
actuarial survival rate of 18% compared with 41.3% for the
gynaecologists. The median survival time was 9.9 months and
29.1 months respectively. Median follow-up (for live cases)
was similar in both groups: 60.7 months for the gynae-
cologists' and 60.1 for the general surgeons' population.
Univariate survival analysis identified prognostic factors as
age, disease stage, residual disease status, surgical procedure,
histology and tumour grade, and the speciality of the
operator (P<0.0001 in each case). Since the distribution of
age, stage, histological type and tumour grade differed
significantly between the two groups, the Kaplan-Meier
analysis was repeated, stratifying by each of these factors,
and survival remained significantly reduced in the general
surgeons' population (P<0.0001) (Table II).
Complete information on 451 patients was available for
multivariate analysis. Univariate analysis was repeated on
this subgroup and confirmed that it was representative of the
larger population. Here again, survival was significantly
poorer in the general surgeons' group (P<0.0001). The 5
year survival of 334 patients under the gynaecologist was
36.1%, as compared with 11.2% for the 117 patients in the
general surgeon's group. The median survival time was 29.1
and 7.4 months respectively.
A stepwise Cox's proportional hazards analysis was under-
taken to determine independent factors which influenced sur-
vival. The results are shown in Table III. Stage, age, residual
disease, surgeon specialty and tumour grade were confirmed
as independent prognostic indicators. The relative risk
(adjusted hazard ratio) of being operated on by a general
surgeon was 1.34 (95% confidence intervals 1.05-1.71). In
the multivariate analysis, individual stages and grouped
stages (I + II vs III + IV) were available for selection, and
the grouped stages selected as the most discriminating
variable. The omission of grouped stages resulted in the
selection of stage I and stage II disease as independent
positive prognostic indicators.
To confirm that 85 patients excluded (because the operator
was unknown) did not adversely affect the results, the sur-
vival pattern of this group was examined. The group was
intermediate between those of the gynaecologist and general
surgeon populations. The 85 patients were included as part
of the general surgeons' group and then the gynaecologists'
group, and this did not alter the significant differences
already found.
The surgical procedures were also examined, for each
disease stage. The significant finding (P<0.05) in stage I
disease was the tendency for general surgeons to undertake
an oophorectomy alone (35.6% of cases) compared with
16.4% of patients under the care of gynaecologists. The age
distribution for both surgical populations was similar. The
management of stage II disease did not differ. In respect of
stage III disease, radical surgery (total abdominal hysterec-
tomy, bilateral salpingo-oophorectomy, with other proce-
dures) was more commonly performed by gynaecologists,
whereas gastrointestinal resection was significantly (P<0.05)
higher in those operated on by general surgeons (3.6% vs
22.4% respectively). In stage IV disease more radical proce-
dures were undertaken by gynaecologists: 32.6% vs 9.5%.
The management of younger patients (i.e. <25 years) for
whom it is assumed that fertility preservation is important,
showed that only two patients were under the care of general
surgeons and 17 under the care of gynaecologists. Preserva-
tion of fertility function was maintained in all except for one
patient in the gynaecologist group. Multivariate analysis was
repeated, with the exclusion of early deaths (<31 days), to
identify the possibility of poor performance influencing the1616 S. KEHOE etal.
outcome differences. Here again, though, analysis of the
remaining 403 cases maintained the operator as an indepen-
dent variable, with survival rates significantly better for
gynaecologists (P= 0.0005). The experience of the surgeon
was examined with respect to the number of operations
performed by individuals. The median number performed by
general surgeons was 3 (range 1-22), and by gynaecologists
was 8 (range 1-33). The inclusion of the variable of fre-
quency of operations did not affect the findings.
survival analysis, n = 1184, per cent survival
after 5 years
General
Gynaecologist surgeon Overall
Stratified by age
<45 66.9 50.9 64.4
45-59 41.9 23.7 38.1
60-74 33.2 15.1 28.1
75+ 34.8 6.3 24.0
Stratified by stage
I 82.2 73.6 81.2
II 37.8 20.0 35.3
III 12.5 5.1 10.1
IV 10.9 0.0 7.1
NK 41.4 27.1 35.7
Stratified by surgerya
Biopsy 4.7 2.1 3.6
Palliative 37.1 18.6 30.0
Radical 54.5 40.3 52.5
Stratified by residual disease
None 76.4 72.3 75.9
<2 cm 20.0 9.9 17.5
>2 cm 8.9 3.1 6.8
NK 42.7 22.2 36.7
Stratified by histology
Serous 32.1 15.3 28.2
Mucinous 66.4 35.3 59.2
Endometrioid 45.6 18.9 43.0
Clear cell 52.9 26.7 45.0
Germ cell 81.6 0.0 73.2
Granulosa/theca cell 85.4 83.3 84.3
Adenocarcinoma 23.5 8.2 18.6
Borderline 97.3 88.9 95.7
Other 0.0 0.0 0.0
NK 32.0 7.7 23.4
Stratified by grade
I 73.3 30.4 65.2
II 29.9 20.6 27.1
III 15.7 3.8 11.7
NK 46.3 25.7 41.2
'Radical procedures, total abdominal hysterectomy +bilateral
salpingo-oophorectomy + other Biopsy, small amount of
tissu for ditic pu Pallative, oophorectony, bowd
surgery/retion, etc., in the face of w d d
Available reports examining the influence of the operator on
patient survival in ovarian cancer are sparse. One series of
patients with stage I and II disease showed that survival was
improved if surgery was performed by a trained gynae-
cological oncologist (Mayer et al., 1992). Similar results were
reported by Eisenkop et al. (1992) in patients with stage IIlc
and IV disease. The largest retrospective series (Nguyen et
al., 1993) analysed long term survival of 5,156 patients from
904 selected hospitals in the US and found a significantly
reduced survival (P<0.004) associated with stage II, III and
IV disease when the patient was operated on by a general
surgeon as compared with a gynaecologist. This series
reaches a similar conclusion, though across all disease
stages.
Various reasons may be forwarded, explaining the
differences found in survival patterns between the popula-
tions studied. The most obvious is that of the patients' age.
Survival in elderly patients with ovarian cancer is poorer
even if adequate surgery and chemotherapy is employed
(Alberts et al., 1993; Marchetti et al., 1993). Therefore, as the
general surgeons' group consisted of older patients (who
conceivably are less likely to be suitable for platinum
exposure), the survival patterns may be unsurprising. How-
ever, stratified analysis shows improved survival when under
the care of the gynaecologists for all age groups, with mul-
tivariate analysis confirming that the surgeons' effect is
independent of the patients' age. This would indicate the
involvement of other factors. Post-operative chemotherapy
practices, which are unknown in the study group, is one
possibility. Tlis possibility is supported by the poorer out-
come of patients with any residual disease when compared
with gynaecologists, although no survival difference was
detected when all macroscopic tumour was excised (Table H).
Having said that, the 5 year survival for patients with stage
HI and IV disease conditional on 1 year survival (a total of
266 patients) resulted in 23.7% survival under gynaecologists
and 13.7% for general surgeons (P= 0.31). Therefore, fur-
ther work is required to ascertain whether or not post-
operative therapeutic approaches do differ. Of note were
three patients under the geneal surgeon who had germ cell
tumours and did not survive. One patient had an early
post-operative death, and the other two were elderly (>70
Tabe m Multivariate analysis on 451 patients (95% confidence intervals)
Adjusted Irnproveent
Factor relative hazard of model fit Adverse factor
Stage
I +11 2.90 (1.69-4.75) P<0.001 Stage III + IV
III + IV
Age per 10 year 1.28 (1.15-1.42) P<0.001 Increasing age
period
Complete tumour dearance
Achieved 2.16 (1.16-4.00) P<0.001 Presence of
Not achieved reidual disea
Tumour grade
1 1.76 (1.22-2.55) P=0.003 Grade II or III
II + III
Residual disease
<2cm 1.54 (1.14-2.09) P=0.002 >2cm
>2cm
Surgeon
Gynaccoogist 1.34 (1.05-1.71) P=0.022 General surgeon
General surg
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years) with widespread intra-abdominal disease, which could
explain the poor outcome of this small group.
Besides age, the referral patterns probably differ as demon-
strated by the higher incidence of bowel resection in those
under the care of general surgeons. General surgeons are
more likely to deal with such patients - a group in a poorer
physical condition, which in some cases require emergency
intervention. Our findings may reflect the inherent adverse
survival patterns associated with such a population. Al-
though a reasonable conclusion, this does not explain the
poorer survival in younger patients and those with stage I/II
disease, operated on by general surgeons. Also of concern is
the fact that general surgeons more often undertake
oophorectomy alone in early-stage disease, which could affect
survival rates. One interpretation of these findings is the
tendency for the operator to perform procedures they are
trained in, and to limit their surgical approach in unfamiliar
circumstances. The differences in the frequency of general
surgeons and gynaecologists in operating on patients could
lead to the assumption that experience alone is an important
factor. Reports on this aspect pertaining to bladder cancer
(Guillford et al., 1991) suggest that variables other than
experience account for differing survival patterns, though
series on oesophageal cancer (Matthews et al., 1986) found
surgical experience a contributor to survival rates.
The importance of prognostic factors in any malignancy
cannot be adequately sressed. More often than not, these
variables are outside the patients' and doctors' control. Iden-
tifying prognostic indicators which are amenable to change
gives rise to the possibility of altering practice and
influencing survival, which is particularly relevant to ovarian
cancer. We recognise the inherent dangers of retrospective
analysis and that other factors may account for some of the
results in this study. Such variables can only be eliminated by
a prospective randomised trial, the ethics of which would be
questionable. The accuracy of information available is
another variable, and an estimate error of 3% can be
assumed by the fact that 18 patients did not have malignancy
and 33 were duplicate records.
We suggest that the evidence from this series is sufficient to
justify a recomnendation that every attempt should be made
to ensure that all patients with ovarian pathology are treated
by or have the involvement of a trained gynaecologist.
Adherence to such a policy could well improve patient sur-
vival in ovarian cancer.
The authors would like to thank Val Redman (West Midland Cancer
Registry) for collecting the files on all the patients.
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